Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

S&P 500 (SPX)

Real-time capital.com
Currency in USD
Disclaimer
5,007.75
-63.88(-1.26%)
Real-time Data

S&P 500 Discussions

https://www.wsj.com/articles/gilead-says-remdesivir-as-effective-treating-severe-covid-19-in-shorter-period-11588166509?mod=article_inline So this is beeing ignored?
I could only read the very beginning, but same exact think happened last time. It really doesn't matter if it's true. It will be passed off as Chinese propaganda.
 "Gilead, China Researchers Report Mixed Results for Potential Covid-19 Drug Gilead said its drug remdesivir showed a benefit in a U.S.-funded study, but other researchers said a study in China didn’t find the drug helped"   In my world this would at least slow down the rally after the Gilead vauge news the met end point of study...
 are all future stimulus packages also already priced in? Is the rest of all future already priced in? Or is it only bad news is priced in, but not the good news?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.